Are the sensorimotor control capabilities of the hands the factors influencing hand function in people with schizophrenia?
Assessments
Hand function
Motor control
Schizophrenia
Sensorimotor
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
07 11 2023
07 11 2023
Historique:
received:
16
06
2023
accepted:
07
10
2023
medline:
9
11
2023
pubmed:
8
11
2023
entrez:
8
11
2023
Statut:
epublish
Résumé
Previous works reported people with schizophrenia experienced inferior hand functions which influence their daily participation and work efficiency. Sensorimotor capability is one of indispensable elements acting in a well-executed feed-forward and feedback control loop to contribute to hand performances. However, rare studies investigated contribution of sensorimotor ability to hand functions for people with schizophrenia. This study aimed to explore hand function in people with schizophrenia based on the perspective of the sensorimotor control capabilities of the hands. Twenty-seven people at the chronic stage of schizophrenia were enrolled. The following assessment tools were used: the Purdue Pegboard Test (PPT) and the VALPAR Component Work Sample-8 (VCWS 8) system for hand function; the Self-Reported Graphic version of the Personal and Social Performance (SRG-PSP) scale for functionality; and the Semmes-Weinstein Monofilaments (SWM), the pinch-holding-up-activity (PHUA) test and the Manual Tactile Test (MTT) for the sensory and sensorimotor parameters. The Clinical Global Impression-Severity (CGI-S) scale and the Extrapyramidal Symptom Rating Scale (ESRS) were used to grade the severity of the illness and the side-effects of the drugs. Spearman's rank correlation coefficient was used to analyze associations among hand function, functionality, and sensorimotor capabilities. A multiple linear regression analysis was used to identify the determinants of hand function. The results indicated that both hand function and sensorimotor capability were worse in people with schizophrenia than in healthy people, with the exception of the sensory threshold measured with the SWM. Moreover, the sensorimotor abilities of the hands were associated with hand function. The results of the regression analysis showed that the MTT measure of stereognosis was a determinant of the PPT measure of the dominant hand function and of the performance on the VCWS 8, and that the ESRS and the MTT measure of barognosis were determinants of the performance on the assembly task of the PPT. The findings suggested that sensorimotor capabilities, especially stereognosis and barognosis, are crucial determinants of hand function in people with schizophrenia. The results also revealed that the side effects of drugs and the duration of the illness directly affect hand function. ClinicalTrials.gov , identifier NCT04941677, 28/06/2021.
Sections du résumé
BACKGROUND
Previous works reported people with schizophrenia experienced inferior hand functions which influence their daily participation and work efficiency. Sensorimotor capability is one of indispensable elements acting in a well-executed feed-forward and feedback control loop to contribute to hand performances. However, rare studies investigated contribution of sensorimotor ability to hand functions for people with schizophrenia. This study aimed to explore hand function in people with schizophrenia based on the perspective of the sensorimotor control capabilities of the hands.
METHODS
Twenty-seven people at the chronic stage of schizophrenia were enrolled. The following assessment tools were used: the Purdue Pegboard Test (PPT) and the VALPAR Component Work Sample-8 (VCWS 8) system for hand function; the Self-Reported Graphic version of the Personal and Social Performance (SRG-PSP) scale for functionality; and the Semmes-Weinstein Monofilaments (SWM), the pinch-holding-up-activity (PHUA) test and the Manual Tactile Test (MTT) for the sensory and sensorimotor parameters. The Clinical Global Impression-Severity (CGI-S) scale and the Extrapyramidal Symptom Rating Scale (ESRS) were used to grade the severity of the illness and the side-effects of the drugs. Spearman's rank correlation coefficient was used to analyze associations among hand function, functionality, and sensorimotor capabilities. A multiple linear regression analysis was used to identify the determinants of hand function.
RESULTS
The results indicated that both hand function and sensorimotor capability were worse in people with schizophrenia than in healthy people, with the exception of the sensory threshold measured with the SWM. Moreover, the sensorimotor abilities of the hands were associated with hand function. The results of the regression analysis showed that the MTT measure of stereognosis was a determinant of the PPT measure of the dominant hand function and of the performance on the VCWS 8, and that the ESRS and the MTT measure of barognosis were determinants of the performance on the assembly task of the PPT.
CONCLUSIONS
The findings suggested that sensorimotor capabilities, especially stereognosis and barognosis, are crucial determinants of hand function in people with schizophrenia. The results also revealed that the side effects of drugs and the duration of the illness directly affect hand function.
CLINICAL TRAIL REGISTRATION
ClinicalTrials.gov , identifier NCT04941677, 28/06/2021.
Identifiants
pubmed: 37936136
doi: 10.1186/s12888-023-05259-w
pii: 10.1186/s12888-023-05259-w
pmc: PMC10631069
doi:
Banques de données
ClinicalTrials.gov
['NCT04941677']
Types de publication
Clinical Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
807Informations de copyright
© 2023. The Author(s).
Références
Front Psychiatry. 2020 Oct 27;11:519248
pubmed: 33192644
J Formos Med Assoc. 2013 Jun;112(6):332-7
pubmed: 23787010
Healthcare (Basel). 2022 May 18;10(5):
pubmed: 35628074
Disabil Rehabil. 2007 Apr 15;29(7):567-75
pubmed: 17453977
J Appl Psychol. 1948 Jun;32(3):234-47
pubmed: 18867059
J Hand Ther. 1993 Jan-Mar;6(1):23-8
pubmed: 8343871
Cogn Neuropsychiatry. 2002 May;7(2):139-56
pubmed: 16571532
J Orthop Res. 2011 Aug;29(8):1210-5
pubmed: 21374708
Brain. 2019 Jul 1;142(7):2149-2164
pubmed: 31099820
Psychiatry (Edgmont). 2007 Jul;4(7):28-37
pubmed: 20526405
Schizophr Res. 2014 Nov;159(2-3):546-51
pubmed: 25257944
J Hand Surg Am. 2010 Aug;35(8):1317-22
pubmed: 20655151
Schizophr Res. 2020 Aug;222:267-273
pubmed: 32461087
Schizophr Res. 2020 Jan;215:197-203
pubmed: 31662233
CNS Neurosci Ther. 2018 Aug;24(8):677-684
pubmed: 29879292
J Hand Surg Br. 2005 Jun;30(3):252-64
pubmed: 15862365
Behav Res Methods. 2009 Nov;41(4):1149-60
pubmed: 19897823
Psychiatry Res. 2013 Apr 30;212(1):73-8
pubmed: 23484867
Biomark Neuropsychiatry. 2020 Jun;2:
pubmed: 33738459
Am J Psychiatry. 2005 Dec;162(12):2384-6
pubmed: 16330607
Psychiatry Res. 2009 Sep 30;169(2):178-9
pubmed: 19646764
Arch Phys Med Rehabil. 2016 Jun;97(6):983-90
pubmed: 26829761
J Psychiatr Res. 2006 Apr;40(3):200-6
pubmed: 16039670
Schizophr Res. 2003 Aug 1;62(3):269-73
pubmed: 12837524
Motor Control. 2014 Jan;18(1):29-43
pubmed: 24496877
Occup Ther Int. 2015 Jun;22(2):94-103
pubmed: 25783143
PLoS One. 2014 Apr 10;9(4):e94452
pubmed: 24722361
Disabil Rehabil. 2019 Jun;41(12):1396-1402
pubmed: 29327599
Neuropsychobiology. 2012;66(2):77-92
pubmed: 22814247
Psychiatry Res. 2015 Jun 30;227(2-3):265-9
pubmed: 25882098
Neurosci Res. 2016 Mar;104:44-51
pubmed: 26592778
J Orthop Res. 2009 Aug;27(8):1116-21
pubmed: 19195027
Psychiatry Res. 2016 Jul 30;241:256-62
pubmed: 27203153
Front Neurol. 2014 Apr 09;5:48
pubmed: 24782821
Psychiatry Res. 2007 Jun 30;151(3):189-99
pubmed: 17412427
Front Psychiatry. 2017 Jul 10;8:120
pubmed: 28740470
Schizophr Res. 2005 Jul 15;76(2-3):247-65
pubmed: 15949657
Neuro Endocrinol Lett. 2019 Dec;40(7-8):329-332
pubmed: 32304370
World J Biol Psychiatry. 2011 Dec;12(8):560-73
pubmed: 21428729
Phys Ther. 2002 Mar;82(3):249-56
pubmed: 11869153
Arch Phys Med Rehabil. 2013 Mar;94(3):451-8
pubmed: 22885285